Peptide hormones are an important category of signaling molecules that are synthesized and secreted by various endocrine glands in the human body. These hormones are composed of amino acids and play a crucial role in regulating several physiological functions such as development, metabolism, reproduction, and stress response.
Among these hormones, preptin is a recently discovered peptide hormone that is synthesized mainly by the beta cells in the pancreas. Preptin belongs to a broader hormone family that includes insulin, amylin, and pramlintide.
Research suggests that preptin is primarily involved in amplifying the actions of insulin, which is essential for regulating glucose levels in the body. Insulin resistance is a critical factor in the development of type 2 diabetes. Therefore, understanding how preptin and type 2 diabetes interact can lead to innovative treatments and prevention methods.
In conclusion, peptide hormones such as preptin play a vital role in maintaining optimal physiological functions in the human body. Further research on preptin and its interactions with other hormones can provide valuable insights into the development and treatment of various metabolic disorders, including type 2 diabetes.
Author(s) Details:
K. A. Arul Senghor,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.
V. M. Vinodhni,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.
P. Renuka,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.
S. Rooban,
SRM Medical College Hospital and Research Centre, SRM IST, Chengalpattu, Tamil Nadu, India.
Please see the link here: https://stm.bookpi.org/ACPR-V4/article/view/12925
Keywords: Signaling molecules, type 2 diabetes, metabolic disorders, glucose stimulation